+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin treatment before percutaneous cononary intervention



Statin treatment before percutaneous cononary intervention



Journal of Thoracic Disease 5(3): 335-342



Treatment with 3-hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) improves short-and-long term prognosis in high-risk patients with stable coronary artery disease and in those with acute coronary syndrome and their use is strongly recommended for secondary prevention. Moreover, recent data suggest that statin pre-treatment is associated with a better short- and long-term outcome in patients undergoing percutaneous coronary intervention. Current guidelines for coronary revascularization recommend the use of high-dose of statins before percutaneous coronary intervention to reduce the risk of periprocedural myocardial infarction in statin naïve patients (class IIa A) and in those on chronic statin therapy (class IIa B). However, the beneficial clinical effects elicited by statins in patients undergoing coronary angioplasty may arise not only from a cardiac protection against periprocedural myocardial injury but also from a renal protection against acute kidney injury caused by iodinated contrast media. Actually, statins exert multiple non-lipid lowering (pleiotropic) effects, including improved endothelial function, reduced inflammatory and immuno-modulatory processes, oxidative stress and platelet adhesion, that may contribute to both cardio- and nephro-protection even in the short-term.

(PDF emailed within 1 workday: $29.90)

Accession: 055911333

Download citation: RISBibTeXText

PMID: 23825770


Related references

Meta-analysis of published reports on the effect of statin treatment before percutaneous coronary intervention on periprocedural myonecrosis. American Journal of Cardiology 100(5): 770-776, 2007

The prognostic value of very low admission LDL-cholesterol levels in ST-segment elevation myocardial infarction compared in statin-pretreated and statin-naive patients undergoing primary percutaneous coronary intervention. International Journal of Cardiology 167(2): 458-463, 2014

Statin treatment improves plasma lipid levels but not HDL subclass distribution in patients undergoing percutaneous coronary intervention. Lipids 48(2): 127-137, 2013

Effect of cardiac rehabilitation and statin treatment on anti-HSP antibody titers in patients with coronary artery disease after percutaneous coronary intervention. International Heart Journal 47(5): 671-682, 2006

Impact of gender difference on long-term outcomes of percutaneous coronary intervention for coronary artery disease in patients under statin treatment. Heart and Vessels 32(1): 16-21, 2016

Density functional study on the high catalytic performance of single metal atoms on the NbC(001) surface. Physical Chemistry Chemical Physics 20(15): 10302-10310, 2018

Dental pain and oral health-related quality of life in individuals with severe dental anxiety. Acta Odontologica Scandinavica 76(6): 401-406, 2018

Pre-percutaneous coronary intervention statin therapy: is it necessary?. American Heart Journal 168(2): E11, 2014

Preprocedural statin therapy in percutaneous coronary intervention. Annals of PharmacoTherapy 41(10): 1687-1693, 2007

Preprocedural statin use in patients undergoing percutaneous coronary intervention. American Heart Journal 168(1): 110-6.E3, 2014

Effect of Statin Treatment and Low-Density Lipoprotein-Cholesterol on Short-Term Mortality in Acute Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention - Multicenter Registry From Tokyo CCU Network Database. Circulation Journal 80(2): 461-468, 2016

Statin loading before percutaneous coronary intervention: proposed mechanisms and applications. Future Cardiology 6(5): 579-589, 2011

Myonecrosis after elective percutaneous coronary intervention: effect of clopidogrel-statin interaction. Journal of Invasive Cardiology 17(11): 589-593, 2005

Statin therapy and long-term clinical outcomes following percutaneous coronary intervention. 2007

Statin loading before percutaneous coronary intervention to reduce periprocedural myocardial infarction. Cardiology in Review 20(6): 319-324, 2013